COVID-19

China approves first patent for COVID-19 vaccine

China has granted its first patent for a COVID-19 vaccine. The vaccine is being developed by a team from the Academy of Military Medical Sciences and the company CanSino Biologics.

Phase-two clinical trials suggest it is safe and can induce an immune response. Phase-three trials are currently underway. #covid19 #vaccine

Subscribe to us on YouTube:
Download our APP on Apple Store (iOS):
Download our APP on Google Play (Android):

Follow us on:
Website:
Facebook:
Twitter:
Instagram:
Pinterest:
Weibo:
Douyin: